The necessity of a standardized quality of sublingual immunotherapy;Notwendigkeit einer standardisierten qualität der sublingualen immuntherapie

Allergo Journal

Volumn 14, Issue 4, 2005, Pages 253-254

  Maetzke, Julia ^a   Hinrichs, Ralf ^a   Scharffetter Kochanek, Karin ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRASS POLLEN EXTRACT;

ALLERGIC CONJUNCTIVITIS; GRASS POLLEN; IMMUNOTHERAPY; LETTER; QUALITY CONTROL; RHINOCONJUNCTIVITIS; STANDARD;

EID: 20644460778     PISSN: 09418849     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03370462     Document Type: Letter

References (15)

1. André C. The development of sublingual immunotherapy. Recent Res Devel Allergy & Clin Immunol 2001; 2: 45-53
2. André C, Perrin Fayolle M, Grosclaude M, Couturier P, Basset D, Cornillon J, Piperno D, Girodet B, Sanchez R, Vallon C, Bellier P, Nasr M. A double blind placebo controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis. Int Arch Allergy Immunol 2003; 131: 111-8
3. Bousquet J, Cauwenberge P van, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (5 Suppl): 8147-334
4. Bufe A. Die heilsame Spritze: Die spezifische Immuntherapie und Ihre Möglichkeiten. Pädiatrische Allergologie in Klinik und Praxis 2003; 1/03: 19-22
5. Bufe A, Ziegler Kirbach E, Stoeckmann E, Heidemann P, Gelhar K, Holland Letz T, Braun W. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double blind placebo controlled study. Allery 2004; 59: 498-504
6. Chapman MD, Heymann PW, Wilkins SR, Brown MJ, Platts Mills TA. Monoclonal immunoassays for major dust mite (Dermatophagoides) allergens, Der p 1 and Der f 1, and quantitative analysis of the allergen content of mite and house dust extracts. J Allergy Clin Immunol 1987; 80: 184-94
7. Durham S. Grass pollen tablet immunotherapy - an international multi centre trial. Oral presentation, XXIII Congress of the EAACI 2004, Amsterdam
8. Durham S, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, Till SJ, Qutayba AH, Kayhan TN. Long term clinical efficacy of grass pollen immunotherapy. N Engl J Med 1999; 341: 468-75
9. Guez S, Vatrinet C, Fadel R, Andre C. House dust mite sublingual swallow immunotherapy (SLIT) in perennial rhinitis: a double blind, placebo controlled study. Allergy 2000; 55: 369-75
10. Haugaard L, Dahl R, Jacobsen L. A controlled dose response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects. J Allergy Clin Immunol 1993; 91: 709-22
11. Khinchi MS, Poulsen LK, Carat F, André C, Hansen AB, Malling HJ. Clinical efficacy of sublingual and subcutaneous birch pollen allergen specific immunotherapy: a randomized, placebo controlled double blind, double dummy study. Allergy 2004; 59: 45-53
12. Ojeda I, Cozalo Reques F, Ojeda P, Estrada JL, Martin S, Rico P. Tolerance of sublingual immunotherapy of grasses administered in disposable monodose vials. Poster 795, XXII Congress of the EAACI 2003, Paris
13. Ree R van. IR, STU, AU, UA, TU, SQ, HEPL... gibt es eine gute Alternative? Allergologie 2003; 26: 352
14. Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV, Hammermann J, Leupold W, Bartels P, Gruebl A, Bauer CP, Schnitker J, Wahn U, Niggemann B. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004; 59: 1285-93
15. Wilson DR, Torres Lima M, Durham S. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev. 2003; CD002893